Tag: NET

Dual-energy CT may improve detection of acute small bowel ischemia

Cabozantinib In Advanced Neuroendocrine Tumors

byDaniel Goldshteinand1 others

October 7, 2024

1. Progression-free survival had a hazard ratio of 0.38 (extrapancreatic NETs) and 0.23 (pancreatic NETs) for those treated with cabozantinib ...

MRI helps predict risk of local recurrence in upper rectal cancers

177Lu-Dotatate plus octreotide was not superior in overall survival compared to octreotide alone for neuroendocrine tumours

byJamie Parkand1 others

December 1, 2021

1. The median overall survival for patients receiving177Lu-Dotatate and intramuscular, long-acting octreotide was 47.0 months and 36.3 months respectively 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: NET

Cabozantinib In Advanced Neuroendocrine Tumors

177Lu-Dotatate plus octreotide was not superior in overall survival compared to octreotide alone for neuroendocrine tumours

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits